Trials / Completed
CompletedNCT01751516
PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study
PET/MRI as a Predictor for Response to Preoperative Radiation Therapy and Chemotherapy in Resectable Rectal Cancer: a Pilot Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm, single center pilot study of 40 patients with uT3N0 or uT1-3N+ rectal cancer receiving pre-operative chemoradiation. Subjects will undergo PET/MRI scans before and after surgery.
Detailed description
The primary purpose of this study is to determine the negative predictive value of PET/MRI for determining pathological complete response from neoadjuvant chemoradiation.
Conditions
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-08-01
- Completion
- 2018-03-04
- First posted
- 2012-12-18
- Last updated
- 2021-01-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01751516. Inclusion in this directory is not an endorsement.